While anti-PD1 therapy did not impact tumor growth nor the well-being of the animals, subcutaneous tumor growth in Hgf-Cdk4R24C mice was significantly reduced in CpG 1688 treated animals at day 22 (Fig 6D) (which was the latest time-point when all animals were still alive). The gene discussed is PDCD1; the disease is neoplasm.